CommercialCoverageMedium impact
Preventive Coverage of Clesrovimab (Enflonsia) for Commercial Members (Retroactively Effective 08/04/2025)
Independence Blue Cross·Infectious Disease, Pediatrics, Pulmonology·News & Announcements
Effective date
Aug 4, 2025
We identified it
Jun 19, 2026
Summary
Commercial insurance plans will now provide preventive coverage for Clesrovimab (Enflonsia), retroactively effective from August 4, 2025. This represents a new covered benefit for commercial members that billing teams can now process for reimbursement.
Action Required
Immediately: Billing team should verify coverage eligibility for Clesrovimab (Enflonsia) claims for commercial members with dates of service on or after August 4, 2025. Update billing system to reflect preventive coverage status for this medication. Contact payer for specific billing guidelines and any required documentation if not already established.